Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    DTP Vaccine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 9Boostrix

    02 4Infanrix, Pediarix

    03 5Infanrix/Pediarix

    04 8Tetrabik

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Infanrix/Pediarix

    Diphtheria, Tetanus Acellular, and Pertussis

    arrow
    OTS 2025
    Not Confirmed

    Brand Name : Infanrix/Pediarix

    United Kingdom
    arrow
    OTS 2025
    Not Confirmed

    GlaxoSmithKline

    Diphtheria, Tetanus Acellular, and Pertussis

    Main Therapeutic Indication : Vaccine

    Currency : USD

    2020 Revenue in Millions : 764

    2019 Revenue in Millions : 1,016

    Growth (%) : -25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Boostrix

    Diphtheria, Tetanus Acellular, and Pertussis

    arrow
    OTS 2025
    Not Confirmed

    Brand Name : Boostrix

    United Kingdom
    arrow
    OTS 2025
    Not Confirmed

    GlaxoSmithKline

    Diphtheria, Tetanus Acellular, and Pertussis

    Main Therapeutic Indication : Vaccine

    Currency : USD

    2020 Revenue in Millions : 660

    2019 Revenue in Millions : 810

    Growth (%) : -18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Tetrabik

    Diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)

    arrow
    OTS 2025
    Not Confirmed

    Brand Name : Tetrabik

    Japan
    arrow
    OTS 2025
    Not Confirmed

    Mitsubishi Tanabe

    Diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)

    Main Therapeutic Indication : Vaccine

    Currency : USD

    2020 Revenue in Millions : 98

    2019 Revenue in Millions : 84

    Growth (%) : 16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Tetrabik

    Diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)

    arrow
    OTS 2025
    Not Confirmed

    Brand Name : Tetrabik

    Japan
    arrow
    OTS 2025
    Not Confirmed

    Mitsubishi Tanabe

    Diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)

    Main Therapeutic Indication : Vaccine

    Currency : USD

    2021 Revenue in Millions : 90

    2020 Revenue in Millions : 96

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Infanrix/Pediarix

    Diphtheria, Tetanus Acellular, and Pertussis

    arrow
    OTS 2025
    Not Confirmed

    Brand Name : Infanrix/Pediarix

    United Kingdom
    arrow
    OTS 2025
    Not Confirmed

    GlaxoSmithKline

    Diphtheria, Tetanus Acellular, and Pertussis

    Main Therapeutic Indication : Vaccine

    Currency : USD

    2021 Revenue in Millions : 735

    2020 Revenue in Millions : 755

    Growth (%) : -1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Boostrix

    Diphtheria, Tetanus Acellular, and Pertussis

    arrow
    OTS 2025
    Not Confirmed

    Brand Name : Boostrix

    United Kingdom
    arrow
    OTS 2025
    Not Confirmed

    GlaxoSmithKline

    Diphtheria, Tetanus Acellular, and Pertussis

    Main Therapeutic Indication : Vaccine

    Currency : USD

    2021 Revenue in Millions : 705

    2020 Revenue in Millions : 652

    Growth (%) : 9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Tetrabik

    Diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)

    arrow
    OTS 2025
    Not Confirmed

    Brand Name : Tetrabik

    Japan
    arrow
    OTS 2025
    Not Confirmed

    Mitsubishi Tanabe

    Diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 70

    2021 Revenue in Millions : 88

    Growth (%) : -20

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Boostrix

    Diphtheria, Tetanus Acellular, and Pertussis

    arrow
    OTS 2025
    Not Confirmed

    Brand Name : Boostrix

    United Kingdom
    arrow
    OTS 2025
    Not Confirmed

    GSK

    Diphtheria, Tetanus Acellular, and Pertussis

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 732

    2021 Revenue in Millions : 705

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Infanrix, Pediarix

    Diphtheria, Tetanus Acellular, and Pertussis

    arrow
    OTS 2025
    Not Confirmed

    Brand Name : Infanrix, Pediarix

    United Kingdom
    arrow
    OTS 2025
    Not Confirmed

    GSK

    Diphtheria, Tetanus Acellular, and Pertussis

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 732

    2021 Revenue in Millions : 735

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Infanrix, Pediarix

    DTP Vaccine

    arrow
    OTS 2025
    Not Confirmed

    Brand Name : Infanrix, Pediarix

    United Kingdom
    arrow
    OTS 2025
    Not Confirmed

    GSK

    DTP Vaccine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2023 Revenue in Millions : 598

    2022 Revenue in Millions : 732

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF